Liver Steatosis Assessed by Controlled Attenuation Parameter (CAP) Measured with the XL Probe of the FibroScan: A Pilot Study Assessing Diagnostic Accuracy

Ultrasound in Medicine and Biology

Volumn 42, Issue 1, 2016, Pages 92-103

  Sasso, Magali ^a   Audière, Stéphane ^a   Kemgang, Astrid ^b   Gaouar, Farid ^b   Corpechot, Christophe ^b   Chazouillères, Olivier ^b   Fournier, Céline ^c   Golsztejn, Olivier ^d   Prince, Stéphane ^d   Menu, Yves ^d   Sandrin, Laurent ^a   Miette, Véronique ^a  

^a Unicancer   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c Medical Affairs Department   (France)

^d HÔPITAL SAINT ANTOINE   (France)

Author keywords

Controlled attenuation parameter (CAP); Elastography; FibroScan; Liver; Non alcoholic fatty liver disease (NAFLD); Steato hepatitis; Steatosis; Ultrasound attenuation; Vibration controlled transient elastography (VCTE)

Indexed keywords

DIAGNOSIS; LIVER; MAGNETIC RESONANCE IMAGING; MEDICAL IMAGING; ULTRASONIC APPLICATIONS; ULTRASONIC EFFECTS; ULTRASONIC WAVES;

CONTROLLED ATTENUATION PARAMETER (CAP); ELASTOGRAPHY; FIBROSCAN; NON-ALCOHOLIC FATTY LIVER DISEASE; STEATO-HEPATITIS; STEATOSIS; TRANSIENT ELASTOGRAPHY; ULTRASOUND ATTENUATION;

PROBES;

ADULT; AREA UNDER THE CURVE; ARTICLE; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ELASTOGRAPH; ELASTOGRAPHY; FATTY LIVER; FEMALE; HUMAN; IN VIVO STUDY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MECHANICAL PROBE; MEDICAL ASSESSMENT; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PHANTOM; PILOT STUDY; RADIATION ATTENUATION; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; SIMULATION; DEVICES; ECHOGRAPHY; IMAGING PHANTOM; LIVER; PROCEDURES;

AREA UNDER CURVE; COHORT STUDIES; FATTY LIVER; FEMALE; HUMANS; LIVER; MALE; MIDDLE AGED; PHANTOMS, IMAGING; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS; ROC CURVE; ULTRASONOGRAPHY;

EID: 84941788436     PISSN: 03015629     EISSN: 1879291X     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2015.08.008     Document Type: Article

References (47)

1. Audiere, S., Clet, M., Sasso, M., Sandrin, L., Miette, V., Influence of heterogeneities on ultrasound attenuation for liver steatosis evaluation (CAP): Relevance of a liver guidance tool. Ultrasonics Symposium (IUS), 2013 IEEE International, 2013, 401–404.
2. Bohte, A.E., van Werven, J.R., Bipat, S., Stoker, J., The diagnostic accuracy of US, CT, MRI and 1 H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: A meta-analysis. Eur Radiol 21 (2011), 87–97.
3. Bossuyt, P.M., Reitsma, J.B., Bruns, D.E., Gatsonis, C.A., Glasziou, P.P., Irwig, L.M., Lijmer, J.G., Moher, D., Rennie, D., de Vet, H.C., Standards for Reporting of Diagnostic A. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative. Ann Intern Med 138 (2003), 40–44.
4. Bravo, A.A., Sheth, S.G., Chopra, S., Liver biopsy. N Engl J Med 344 (2001), 495–500.
5. Burckhardt, C.B., Speckle in Ultrasound B-Mode Scans. IEEE Trans Sonics Ultrason 25 (1978), 1–6.
6. Castera, L., Foucher, J., Bernard, P.H., Carvalho, F., Allaix, D., Merrouche, W., Couzigou, P., de Ledinghen, V., Pitfalls of liver stiffness measurement: A 5-year prospective study of 13,369 examinations. Hepatology 51 (2010), 828–835.
7. Chalasani, N., Younossi, Z., Lavine, J.E., Diehl, A.M., Brunt, E.M., Cusi, K., Charlton, M., Sanyal, A.J., The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55 (2012), 2005–2023.
8. Chan, W.K., Nik Mustapha, N.R., Mahadeva, S., Controlled attenuation parameter for the detection and quantification of hepatic steatosis in non-alcoholic fatty liver disease. J Gastroenterol Hepatol 29 (2014), 1470–1476.
9. Chon, Y.E., Jung, K.S., Kim, S.U., Park, J.Y., Park, Y.N., Kim do, Y., Ahn, S.H., Chon, C.Y., Lee, H.W., Park, Y., Han, K.H., Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: A prospective study of a native Korean population. Liver Int 34 (2014), 102–109.
10. de Ledinghen, V., Vergniol, J., Transient elastography (FibroScan). Gastroenterol Clin Biol 32 (2008), 58–67.
11. de Ledinghen, V., Vergniol, J., Foucher, J., Merrouche, W., le Bail, B., Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography. Liver Int 32 (2012), 911–918.
12. Farrell, G.C., George, G., de la, M., Hall, P., Mc Cullough, A.J., Fatty liver disease: NASH and related disorders. 2004, Blackwell Publishing, Oxford, UK.
13. Farrell, G.C., Larter, C.Z., Nonalcoholic fatty liver disease: From steatosis to cirrhosis. Hepatology 43 (2006), S99–S112.
14. Ferraioli, G., Tinelli, C., Lissandrin, R., Zicchetti, M., Dal Bello, B., Filice, G., Filice, C., Controlled attenuation parameter for evaluating liver steatosis in chronic viral hepatitis. World J Gastroenterol 20 (2014), 6626–6631.
15. Fleiss, J.L., Levin, B., Paik, M.C., The measurement of interrater agreement. Stat Methods Rates Proportions 2 (1981), 212–236.
16. Foucher, J., Castera, L., Bernard, P.H., Adhoute, X., Laharie, D., Bertet, J., Couzigou, P., de Ledinghen, V., Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol 18 (2006), 411–412.
17. Gallop, R.J., Crits-Christoph, P., Muenz, L.R., Tu, X.M., Determination and interpretation of the optimal operating point for ROC curves derived through generalized linear models. Understanding Stat 2 (2003), 219–242.
18. Goss, S.A., Frizzell, L.A., Dunn, F., Ultrasonic absorption and attenuation in mammalian tissues. Ultrasound Med Biol 5 (1979), 181–186.
19. Jensen, J.A., Field: A program for simulating ultrasound systems. 10th Nordicbaltic conference on Biomedical Imaging 4 (1996), 351–353.
20. Jensen, J.A., Nikolov, S.I., Fast simulation of ultrasound images. Ultrasonics Symposium, 2000 IEEE 2 (2000), 1721–1724.
21. Jensen, J.A., Gandhi, D., O'Brien, W.D. Jr., Ultrasound fields in an attenuating medium. Ultrasonics Symposium, 1993 Proceedings, IEEE 1993 (1993), 943–946.
22. Jung, K.S., Kim, B.K., Kim, S.U., Chon, Y.E., Cheon, K.H., Kim, S.B., Lee, S.H., Ahn, S.S., Park, J.Y., Kim, D.Y., Ahn, S.H., Park, Y.N., Han, K.H., Factors affecting the accuracy of controlled attenuation parameter (CAP) in assessing hepatic steatosis in patients with chronic liver disease. PLoS One, 9, 2014, e98689.
23. Karlas, T., Petroff, D., Garnov, N., Bohm, S., Tenckhoff, H., Wittekind, C., Wiese, M., Schiefke, I., Linder, N., Schaudinn, A., Busse, H., Kahn, T., Mossner, J., Berg, T., Troltzsch, M., Keim, V., Wiegand, J., Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1 h-mr spectroscopy. PLoS One, 9, 2014, e91987.
24. Katz, M.H., Multivariable analysis: A practical guide for clinicians and public health researchers. 2011, Cambridge University Press, Cambridge, UK.
25. Kleiner, D.E., Brunt, E.M., Van Natta, M., Behling, C., Contos, M.J., Cummings, O.W., Ferrell, L.D., Liu, Y.C., Torbenson, M.S., Unalp-Arida, A., Yeh, M., McCullough, A.J., Sanyal, A.J., Nonalcoholic Steatohepatitis Clinical Research N. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 (2005), 1313–1321.
26. Kuc, R., Schwartz, M., Estimating the acoustic attenuation coefficient slope for liver from reflected ultrasound signals. IEEE Trans Son Ultrason 26 (1979), 353–361.
27. Kuc, R., Clinical application of an ultrasound attenuation coefficient estimation technique for liver pathology characterization. IEEE Trans Biomed Eng 27 (1980), 312–319.
28. Kumar, M., Rastogi, A., Singh, T., Behari, C., Gupta, E., Garg, H., Kumar, R., Bhatia, V., Sarin, S.K., Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: Does etiology affect performance?. J Gastroenterol Hepatol 28 (2013), 1194–1201.
29. Lilliefors, H.W., On the Kolmogorov-Smirnov test for normality with mean and variance unknown. J Am Stat Assoc 62 (1967), 399–402.
30. Madsen, E.L., Zagzebski, J.A., Macdonald, M.C., Frank, G.R., Ultrasound focal lesion detectability phantoms. Med Phys 18 (1991), 1171–1180.
31. Maklad, N.F., Ophir, J., Balsara, V., Attenuation of ultrasound in normal liver and diffuse liver disease in vivo. Ultrason Imaging 6 (1984), 117–125.
32. Mi, Y.Q., Shi, Q.Y., Xu, L., Shi, R.F., Liu, Y.G., Li, P., Shen, F., Lu, W., Fan, J.G., Controlled attenuation parameter for noninvasive assessment of hepatic steatosis using Fibroscan: Validation in chronic hepatitis B. Dig Dis Sci 60 (2015), 243–251.
33. Mueller, S., Sandrin, L., Liver stiffness: A novel parameter for the diagnosis of liver disease. Hepat Med 2 (2010), 49–67.
34. Myers, R.P., Pollett, A., Kirsch, R., Pomier-Layrargues, G., Beaton, M., Levstik, M., Duarte-Rojo, A., Wong, D., Crotty, P., Elkashab, M., Controlled Attenuation Parameter (CAP): A noninvasive method for the detection of hepatic steatosis based on transient elastography. Liver Int 32 (2012), 902–910.
35. Myers, R.P., Pomier-Layrargues, G., Kirsch, R., Pollett, A., Duarte-Rojo, A., Wong, D., Beaton, M., Levstik, M., Crotty, P., Elkashab, M., Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology 55 (2012), 199–208.
36. Narayana, P.A., Ophir, J., On the frequency dependence of attenuation in normal and fatty liver. IEEE Trans Son Ultrason 30 (1983), 379–382.
37. Raunig, D.L., McShane, L.M., Pennello, G., Gatsonis, C., Carson, P.L., Voyvodic, J.T., Wahl, R.L., Kurland, B.F., Schwarz, A.J., Gonen, M., Zahlmann, G., Kondratovich, M., O'Donnell, K., Petrick, N., Cole, P.E., Garra, B., Sullivan, D.C., Group QTPW. Quantitative imaging biomarkers: A review of statistical methods for technical performance assessment. Stat Methods Med Res 24 (2015), 27–67.
38. Recio, E., Cifuentes, C., Macias, J., Mira, J.A., Parra-Sanchez, M., Rivero-Juarez, A., Almeida, C., Pineda, J.A., Neukam, K., Interobserver concordance in controlled attenuation parameter measurement, a novel tool for the assessment of hepatic steatosis on the basis of transient elastography. Eur J Gastroenterol Heptaol 25 (2013), 905–911.
39. Sandrin, L., Fourquet, B., Hasquenoph, J.M., Yon, S., Fournier, C., Mal, F., Christidis, C., Ziol, M., Poulet, B., Kazemi, F., Beaugrand, M., Palau, R., Transient elastography: A new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 29 (2003), 1705–1713.
40. Sasso, M., Beaugrand, M., de Ledinghen, V., Douvin, C., Marcellin, P., Poupon, R., Sandrin, L., Miette, V., Controlled attenuation parameter (CAP): A novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol 36 (2010), 1825–1835.
41. Sasso, M., Tengher-Barna, I., Ziol, M., Miette, V., Fournier, C., Sandrin, L., Poupon, R., Cardoso, A.C., Marcellin, P., Douvin, C., de Ledinghen, V., Trinchet, J.C., Beaugrand, M., Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan((R)): Validation in chronic hepatitis C. J Viral Hepat 19 (2012), 244–253.
42. Sasso, M., Audière, S., Sandrin, L., Miette, V., Influence of heterogeneities on liver steatosis evaluation by Fibroscan (CAP): Relevance of a liver guidance tool. Eur J Ultrasound, 34, 2013 PS7_11.
43. Schwenzer, N.F., Springer, F., Schraml, C., Stefan, N., Machann, J., Schick, F., Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 51 (2009), 433–445.
44. Shen, F., Zheng, R.D., Mi, Y.Q., Wang, X.Y., Pan, Q., Chen, G.Y., Cao, H.X., Chen, M.L., Xu, L., Chen, J.N., Cao, Y., Zhang, R.N., Xu, L.M., Fan, J.G., Controlled attenuation parameter for non-invasive assessment of hepatic steatosis in Chinese patients. World J Gastroenterol 20 (2014), 4702–4711.
45. Tang, A., Tan, J., Sun, M., Hamilton, G., Bydder, M., Wolfson, T., Gamst, A.C., Middleton, M., Brunt, E.M., Loomba, R., Lavine, J.E., Schwimmer, J.B., Sirlin, C.B., Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 267 (2013), 422–431.
46. Wagner, R.F., Smith, S.W., Sandrik, J.M., Lopez, H., Statistics of speckle in ultrasound B-scans. IEEE Trans Son Ultrason 30 (1983), 156–163.
47. Wear, K.A., The effect of trabecular material properties on the frequency dependence of backscatter from cancellous bone. J Acoust Soc Am 114 (2003), 62–65.